Persistent infections with high-risk human papillomaviruses (HPVs) induce dysplastic lesions of the lower genital tract. Some of these lesions eventually progress to invasive cancers, particularly of the uterine cervix. In many advanced preneoplastic cervical lesions and most derived carcinomas, HPV genomes are found to be integrated into the host cell chromosomes. Although HPV integration seems to play an important role in the progression of cervical dysplasia, the underlying mechanisms are still unclear. To investigate the pathogenic role of genomic integration of HPV genomes in greater detail, we analysed integration sites of HPV16 and 18 genomes in 21 anogenital precancerous and cancerous lesions using a ligation-mediated chain reaction (DIPS) and the recently described amplification of papilloma virus oncogene transcripts (APOT) assay. On the genomic level, only singular integration events were observed in individual neoplastic cell clones. At many integration sites, a short overlap between HPV and genomic sequences was observed, suggesting that the integration of HPV genomes is mediated by nonhomologous sequence-specific recombination. APOT analysis revealed that the majority of integrated HPV genomes was actively transcribed. These data suggest that in the progression of cervical preneoplasia to invasive carcinomas, integration of viral genomes occurs only at single or few chromosomal loci in a given cell clone. Disruption of cellular genes might support malignant transformation in rare cases; however, it is not a pathogenic prerequisite. The main function of HPV integration seems to be the stabilization of oncogene transcription.
Introduction
Infections with high-risk human papillomaviruses (HRHPVs) are associated with dysplasias and carcinomas particularly in the lower female genital tract. HR-HPVs encode for two well-characterized viral oncogenes, referred to as E6 and E7, which are required to initiate and maintain neoplastic growth of epithelial cells (reviewed by zur Hausen, 2000) . Both viral oncoproteins interact with a variety of cellular factors involved in the regulation and fine tuning of the cell cycle and the cell death machinery (reviewed by Mantovani and Banks, 2001; Duensing and Munger, 2001 ). In addition, both proteins interfere with the ordered synthesis of centrosomes, leading to multipolar mitotic figures and unbalanced distribution of chromosomes during mitosis, a hallmark of chromosomal instability (reviewed by Duensing and Munger, 2002) .
In the normal HPV life cycle, expression of the viral E6 and E7 proteins is required for reactivation of the cellular DNA-replication machinery in terminally differentiated epithelial cells, a prerequesite for viral replication and propagation. Oncogene expression is restricted to cells within the intermediate and upper cell layers of the epithelium. These cells have undergone terminal differentiation and irreversibly arrested their cellular DNA-replication machinery (reviewed by zur Hausen, 2000; von Knebel Doeberitz, 2002) .
In contrast, when the papillomavirus genes are expressed in the nondifferentiated, replicating cells of the basal and parabasal cell layers, the E6 and E7 gene products interfere with the ordered sequence of the cellular DNA-replication machinery, leading to genetic instability and subsequent neoplastic transformation. The accidental coexpression of the full set of cellular DNA-replication factors as well as the viral genes mediating replication of the viral genome result in severe damage of the chromosomal integrity and recombination of diverse DNA sequences (Tlsty, 1997; Lengauer et al., 1998 ; reviewed by Duensing and Munger, 2002) . These include recombination of cellular and viral genome fragments and, consequently, changes in the physical state of the HPV genomes occur during preneoplastic progression of cervical lesions. The development of malignant cells seems to be closely linked to the generation of transformed cell clones with integrated genome copies. In low-grade lesions, the majority of HPV genomes persist in episomal state, whereas in highgrade lesions and carcinomas, an increasing number of HPV genomes is found to be integrated into the host genome (Durst et al., 1985; Schwarz et al., 1985; Lehn et al., 1988) . Different groups have found up to 88% of integrated HPV DNA in cervical carcinomas (Cullen et al., 1991; Klaes et al., 1999) . The integration sites are widely distributed all over the human genome and are unique in each clinical sample (Luft et al., 2001; Wentzensen et al., 2002) , ruling out the involvement of specific integration loci in tumorigenesis, as it is known for retroviral insertional mutagenesis (Butel, 2000) . While HPV integration equates the end of the viral life cycle due to the loss or functional inactivation of large parts of the viral genome, expression of the viral oncogenes E6 and E7 is maintained and even enhanced upon integration, favouring neoplastic transformation and progression (von Knebel Doeberitz et al., 1991; . Despite this evident importance for HPV-mediated neoplastic transformation, not much is known about the exact mechanisms of HPV genome integration. The frequency of HPV integrations seems to differ, some cell lines harbour hundreds of copies at various cellular loci, few analysed clinical samples showed only low numbers of integrated HPV genomes (Durst et al., 1985; Baker et al., 1987; Kalantari et al., 2001; Luft et al., 2001 ). In addition, it is not clear how many of the integrated viral genome copies are transcribed into mRNAs. In the case of the cervical cancer cell line CaSki, it was shown that only one locus of the 300 integrated HPV genomes is transcribed, all other copies are transcriptionally silent (Van Tine et al., 2001) . Different settings of early HPV integration events are conceivable: On the one hand, the chromosomal disturbance might lead to frequent integration of HPV genomes at different chromosomal areas and HPV oncogene expression may be driven by few or just one of the integration sites. On the other hand, HPV integration could be a rather single accident in a cell, and ensuing the integrated HPV genome might be transcribed.
We performed an extended analysis of genomic integration loci of HR-HPV genomes and their transcription pattern in a series of clinical samples of advanced genital dysplastic or neoplastic lesions. Genomic integration sites were determined using the recently described 'Detection of Integrated Papillomavirus Sequences' (DIPS-PCR) (Luft et al., 2001) . This singleside-specific ligation-mediated PCR permits amplification and further characterization of genomic DNA sequences adjacent to integrated HPV16 or 18 fragments. Transcription of integrated and episomal viral genomes was monitored using the 'Amplification of Papillomavirus Oncogene Transcripts (APOT)' assay, a PCR system developed to differentiate between integrate and episome derived HR-HPV E6 and E7 oncogene transcripts (Klaes et al., 1999) . The combination of both methods allowed to estimate the approximate number of integration sites of the viral oncogenes in individual lesions. Furthermore, it provided information about the transcriptional activity of individual integration sites. We found only singular integration events in all cancer samples analysed. The majority of these showed integrate-derived fusion transcripts, all of which corresponded exactly to the respective chromosomal locus as determined by DIPS-PCR.
Results

Overview of analysed clinical samples
A total of 22 biopsy samples that showed integrated HPV16 or HPV18 sequences were analysed. These biopsies include 17 cervical carcinomas, one pelvic lymph node metastasis corresponding to one of these cervical carcinoma samples, two vaginal carcinomas and two cervical carcinoma in situ lesions. Disease stage was mainly T1b, but more advanced cases up to T3 were also analysed. HPV typing was performed using the GP5 þ / 6 þ EIA method. In all, 13 samples were typed HPV16 positive, eight samples were typed HPV18 positive and one cervical carcinoma sample showed a double infection of HPV16 and HPV18 (summarized in Table 1 ).
Detection of the genomic integration locus
To detect the genomic integration locus of HPV DNA, DIPS analysis was used to amplify the downstream fusion region between viral and cellular DNA (Figure 1 ). Sequence analysis of the DIPS amplification products showed the 3 0 disruption site in the HPV genome to be different in all samples and ranging from position 1300 in the HPV E1 gene to 4000 in the HPV E5 gene. In all, 18 of 22 integrated HPV genomes were disrupted in the E1 gene, three in the E2/E4 gene, and one in the E5 gene. The precise genomic integration sites could be identified in all cases except one by database comparison. Supporting previous findings, all integration sites were unique and appeared to be randomly distributed over the human genome, except for the lymph node metastasis (T14LN), which showed the same integration locus as the respective primary tumour (T14). The majority of integration events occurred in transcribed genomic regions: eight genes (MAP4, CDH13, NFIB, DGKB, LRP1B, PCDH7, VMP1, and BIKE) and five loci harbouring EST sequences were affected by HPV integration. All integration sites except one were located in introns of the respective genes. Two integration sites were found in repetitive sequence elements and five in intergenic regions (Table 1) .
The amplification of the direct transition from viral to cellular DNA allowed us to compare viral and cellular sequences with respect to recombination events during integration in 16 cases (Table 2) . No major recombination events involving large genomic areas could be found at the integration sites. However, in 12 of 16 cases, short overlaps of one to six nucleotides between cellular and viral sequences could be observed. Two cases showed a direct transition from viral to cellular Number denotes last viral nucleotide before recombination to human sequence. Numbers preceded by a greater than sign denote the last nucleotide obtained by sequencing.
b HUGO gene name and Unigene cluster/EST Accession number. c in, lies in intron; ex, lies in exon; opp, integrated into the opposite strand; rep, lies in repetitive region; inter, lies in intergenic region; ?, lies in region not yet assigned to any exon or intron.
d A, splice Type A;if no number given for episomal transcripts usual splice acceptor site was used (HPV16 splice acceptor site at nt 3356, HPV18 splice acceptor site at nt 3433), and viral splice donor site was at nt 880 for all HPV16 and at nt 929 for all HPV18 samples. Numbering of HPV sequences according to GeneBank Accession numbers NC_001526 for HPV16 and NC_001357 for HPV18. CIS, carcinoma in situ of uterine cervix; CxCa, cervical cancer; LN, pelvic lymph node metastasis; VaCa, vaginal cancer; E, HPV episom; e, episomal HPV oncogene transcript; I, HPV integrated sequence; i, integrate derived HPV oncogene transcript HPV 16 and 18 integration and transcription C Ziegert et al sequence without sequence identity, and in two cases, a filler sequence of four or nine nucleotides that did neither derive from the viral nor the cellular genome was found at the respective locus.
Detection of integrate derived fusion transcripts
All 22 biopsy samples were subjected to APOT PCR to analyse the transcriptional status of the integrated HPV Figure 1 Basic features of DIPS assay and APOT assay in diagram form. DIPS assay includes (i) restriction enzyme digestion, (ii) ligation of an enzyme-specific double stranded adapter, (iii) first PCR using an HPV16-or HPV18-specific primer set for linear amplification and (iv) second PCR using an HPV16-or HPV18-specific primer set (nested) and an adaptor-specific primer. The DIPS amplicon includes the site of viral disruption as well as the cellular integration site. APOT assay includes (i) reverse transcription of mRNA using a (dT) 17 -p3 primer, (ii) first PCR using an HPV16 or HPV18 E7-specific primer and a p3-specific primer and (iii) second PCR using a HPV16 or HPV18 E7-specific primer (nested) and a (dT) 17 -p3 primer. The APOT amplicon includes the viral splice donor site as well as the cellular splice acceptor site. 'R' denotes the site of restriction enzyme digestion, black boxes represent viral sequences, light grey boxes represent cellular sequences, the dark grey box represents the restriction site-specific adaptor used in DIPS assay, full triangles represent primers used in the first PCR and open triangles represent primers used in the second PCR Last nucleotides of HPV sequence before viral-cellular junction at the HPV integration site. b Overlapping sequence is printed bold, 'D' denotes a gap of base pairs that could neither be assigned to HPV nor to the cellular sequence.
c First nucleotides after viral-cellular junction at the HPV integration site. For HPV numbering, see accession numbers used in Table 1 DNA. HPV-oncogene transcripts could be amplified from all samples. Fusion transcripts were amplified from 15 of 19 carcinoma samples, and from the sample of the lymph node metastasis. In the two carcinoma in situ samples, only episomal transcripts were found. Two carcinoma samples showed both episome and integrate derived oncogene transcripts. All amplification products were excised from the agarose gel and sequenced using HPV E7-specific primers.
Correlation of DIPS and APOT results
Database comparison of the cellular fragments of the fusion transcripts correlated with DIPS data in all cases, that is, all integrate derived transcripts identified by APOT-PCR displayed sequence elements which were also identified by the analysis of the genomic integration using DIPS-PCR.
Owing to the involved splicing mechanism, the fusion transcripts have a different structure than the genomic amplification products. Usually, transcripts are spliced from the E1 splice donor site into the cellular flanking sequence, where a regular or cryptic splice acceptor site is used (Klaes et al., 1999; Wentzensen et al., 2002) . The splicing event could be analysed in 14 cases (Table 3 ). In three of these 14 cases the fusion transcripts were not derived from transcribed areas (T17, T21 and T26). In the other 11 cases (T13, T14/T14LN, T15, T18, T19,  T23, T27 , T29, T30, T31 and T32) fusion transcripts derived from transcriptional active chromosomal areas and their splicing could be compared to the natural mRNA processing. In six of the 11 cases (T14/T14LN, T18, T23, T27, T29 and T30), the transcripts were spliced to the next adjacent splice acceptor sequence of the respective gene close to the integration site. Figure 2 shows three representative examples for splicing events in the analysed samples. Figure 2a shows viral integration in the area of the predicted gene MGC4825. The viral integration site was mapped to an intergenic region close to exon one. The transcript was spliced to the first available splice acceptor site located before exon two, spanning more than 200 000 nucleotides (nt). Figure 2b shows integration into intron two of the NFIB gene. The transcript is spliced to the splice acceptor site of exon three. The following exons until exon six are spliced regularly. Figure 2c shows HPV integration into intron 20 of the LRP1B gene. The transcript is spliced to the exon 28 splice acceptor site and further spliced to exon 25. This aberrant splicing event could be related to major rearrangements at the integration locus. The distance between the genomic integration site and the cellular splice acceptor site varied from 413 to more than 200 000 nt with a median splice distance of 29 958 nt (Table 3) .
In three cervical carcinomas (T22, T24 and T25), one vaginal carcinoma (T28) and the two preinvasive cervical samples (T04 and T05), only episome derived oncogene transcripts, but no fusion transcripts, could be amplified. To analyse, if amplification of fusion transcripts failed due to oversize transcripts as a result of absent splicing, the downstream sequences of the integration sites were analysed for possible splice acceptor sites. The consensus sequence used for this analysis was 'YYYYYYYYYYYYNCAG' for the human splice acceptor site and 'YNYYRAY' for the branch site (reviewed by Mount, 2000) . In all cases, we found splice acceptor sites with associated branch sites not further downstream than 40 kB from the integration site.
Discussion
Expression of the HR-HPV oncogenes E6 and E7 is an essential prerequisite for the initiation and maintenance Number denotes last viral nucleotide before recombination to human sequence. b Number denotes last viral nucleotide before splicing. c Number denotes the cellular integration locus on the affected chromosome found using DIPS.
d Number denotes first nucleotide of the cellular splice acceptor site found using APOT.
e Number denotes total splice distance from viral splice donor site to cellular splice acceptor site.
f Number denotes the number of cellular nucleotides that were omitted during splicing from the integration locus to the cellular splice acceptor site. Owing to the limited HPV sequence information, either viral disruption, the integration loci or the cellular splice acceptor site could not be determined precisly for samples T19, T31, T27 and T26. Numbers preceded by either a less or a greater than sign denote either the first or the last nucleotide obtained by sequencing. For HPV numbering, see accession numbers used in Table 1 of the neoplastic growth of anogenital cancers. In the vast majority of cervical cancers and derived cell lines, the viral genome is integrated into the host cell genome, suggesting that integration essentially contributes to HPV-mediated neoplastic transformation. It was shown that HPV integration leads to deregulated (von Knebel Doeberitz et al., 1991) and enhanced expression of the viral oncogenes and thus favours the selection of cell clones with optimized oncogene expression.
Previous studies demonstrated that some cervical cancer derived cell lines, for example CaSki, harbour many copies of integrated HPV16, whereas only a minor part of the integrated genomes seems to be actively transcribed (Van Tine et al., 2001) . The comparison between the total rate of HPV integration and the integration derived oncogene transcripts in clinical samples can elucidate if HPV integration is a frequent event in single cells, leading to insertional mutagenesis in various cases, or if it is rather singular and mainly provokes stabilization of oncogene expression.
Here, we compared the number and integration loci of HPV genomes and their transcription patterns in 21 cervical and vaginal carcinomas. DIPS analysis (Luft et al., 2001 ) was performed to determine the exact integration sites of the viral DNA into the human genome. The structure and source of the transcribed viral-cellular fusion transcripts was determined by APOT analysis (Klaes et al., 1999) . All detected chromosomal integration sites were unique and differed from previously described integration sites. In agreement with an earlier report, most integrates were derived from transcriptional active chromosomal regions, supporting the theory that transcribed sequences facilitate foreign DNA integration (Wentzensen et al., 2002) . In all samples analysed in this study, only singular integration sites were detected on the genomic level by the DIPS analysis. Therefore, multiple HPV integration sites in a clonal cell population seem to be very rare.
Expression of the viral oncogenes in proliferating cells initiates severe disturbances of the mitotic spindle formation. This may result in a chaotic scenario of recombination, translocation, amplification and deletion of genomic fragments and a 'crisis' of the affected cell population during which most cells will die because of genetic modifications incompatible with further survival. Viral genome fragments may be integrated during this 'crisis' and lead to high-level oncogene expression. The fact that only single or few viral integration sites were encountered in naturally occurring cancers suggests that during HPV-mediated carcinogenesis, HPV-infected cells are selected that have undergone a limited number of recombination events, which led to an optimized expression of the viral oncogenes. The tight correlation of the integration sites identified by the genomic approach (DIPS-PCR) and the transcript-based approach (APOT-PCR) further support this notion and suggest that random destruction of relevant loci by insertional mutagenesis plays a minor role in HPV-mediated carcinogenesis.
DIPS assay and database comparison provided information to exactly determine the details of recombination at the viral-cellular junction in 16 cases; 12 of these cases showed a 1-6 bp homology at the integration site. Short identical sequences at the viral and cellular recombination sites that seem to facilitate viral integration have been described in cell lines (el Awady et al., 1987) and in primary cervical carcinomas (Durst et al., 1986) . This mechanism of nonhomologous recombination including short homologous sequences at the recombination site has also been observed for SV40 integration (Bullock et al., 1984) . In two cases, filler sequences were observed that could neither be found in the HPV nor in the cellular sequence at the respective locus. These inserted sequences could result from major recombination processes involving cellular DNA loops, as it was previously described (Choo et al., 1996; Gallego et al., 1997 APOT analysis was used to characterize integration derived oncogene transcripts and the splicing mechanisms involved in mRNA generation. In all, 15 of the 19 integrated HPV genomes in cancer lesions showed expression of integrate derived fusion transcripts. All analysed fusion transcripts except one were spliced from the E1 splice donor site into flanking cellular sequences, usually using the next adjacent splice acceptor site. In the majority of cases, the exon-intron structure following the integration site was identical to the native genes and all exons were spliced properly. In the case of intergenic or antisense integrations, mRNA was spliced using highly conserved consensus splice signals, representing either cryptic splice sites or random sequences. In one case, the transcript was spliced skipping seven exons including 100 kB of the wild-type genomic sequence. This aberrant splicing points to genomic rearrangements at the integration site, suggesting a partial loss of the gene disrupted by HPV integration.
In six of 21 cervical lesions, we did not detect integration derived fusion transcripts, although DIPS-PCR showed integrated HPV DNA. We analysed the downstream chromosomal surroundings of these integrated HPV genomes. An explanation for the impossibility to amplify expressed transcripts could be aberrant or absent splicing of precursor mRNA leading to very long transcripts inaccessible to APOT-PCR. Analysis for downstream splice acceptor sites showed no difference to the loci where fusion transcripts could be amplified: all loci had highly conserved splice acceptor consensus signals within the regular range of splicing distances observed in this study. To exclude the possibility of oversized, yet spliced, transcripts that have a very low amplification efficiency with the standard APOT protocol, a modified assay optimized for the amplification of sequences up to 20 kB in length was used to amplify those transcripts. None of the cases showed amplification of fusion transcripts with the modified PCR. A possible explanation for the inability to amplify integrate derived trancripts is the presence of abundant episomal transcripts, that can mask the low amplification of coexistent fusion transcripts. Dilution series with cloned episomal and fusion transcripts were performed that showed good amplification efficiency of fusion transcripts up to a 20-fold excess of episomal transcripts. All these samples showed a clear episomal signal by DIPS, albeit an exact quantification was not possible. At last, one cannot exclude the occurence of concatemeric integrated HPV genomes that abundantly express transcripts displaying episomal structure, although they derive from integrated HPV genomes. Apart from that, it might be possible, that the integrated HPV genome is silent because of alterations of the HPV promoter, or by transcriptional silencing driven by surrounding cellular sequences (von Knebel Doeberitz et al., 1991) . However, we assume that the majority of integrated HPV genomes do express integrate derived transcripts and that some could be missed because of amplification problems.
To conclude, we found only single integration events in all analysed samples. Genomewide multiple and repeated integration of HPV DNA seems to be an infrequent event. Integrate derived HPV oncogene transcripts could be amplified from the majority of the integration sites detected by DIPS analysis. Most loci with integrated HPV DNA are actively transcribed, but there is no evidence for a role of insertional mutagenesis in HPV-mediated transformation. Having ruled out a general involvement of specific genomic sites in malignant progression, the major function of HPV integration seems to be the conservation and stabilization of HPV oncogene expression. These findings further underline the critical role of transcription of integrated HPV DNA during neoplastic transformation and suggest that the unique integration sites could be of significant clinical importance as clonal markers in the diagnostic work up and post therapy surveillances of patients with HPVrelated lesions.
Materials and Methods
Clinical samples
Biopsy samples were collected from patients attending the Blokhin Russian Cancer Research Center in Moscow (Russia) and the Department of Gynecology and Obstetrics, University Leipzig (Germany) and were frozen immediately. Total RNA and genomic DNA were extracted from biopsies using RNeasy Mini Kit and DNeasy Tissue Kit, respectively (both Qiagen, Hilden, Germany) following the manufacturer's instructions. HPV typing was performed by GP5 þ /GP6 þ -mediated PCR-EIA as described by Jacobs et al. (1997) . HPV16 and HPV18 positive samples were subjected to both APOT and DIPS assay.
APOT
Total RNA was reverse transcribed and resulting HPV oncogene transcripts were amplified as described before (Klaes et al., 1999) , with minor modifications. Total RNA (500-1000 ng) was transcribed using 10 U of MMLV reverse transcriptase Superscript II (Invitrogen life technologies, Carlsbad, USA) and an adaptor-linked oligo(dT)-Primer (Frohman, 1993) . Subsequent semi-nested PCR was performed using HPV E7-specific 5 0 primers and an 3 0 adaptor primer and an oligo(dT)-primer, respectively. PCR products were blotted onto nylon membranes and hybridized using both E7-and E4-specific probes to discriminate episomal from integration derived transcripts.
DIPS
DIPS assay was performed as described previously (Luft et al., 2001) , with minor modifications. Digestion of 1.2 mg genomic DNA by restriction endonuclease Sau3AI was followed by ligation of an enzyme-specific double-stranded adaptor containing a double-and a single-stranded part ('vectorettefeature'). After the first linear PCR using distinct viral primers for HPV16 and HPV18, a second PCR step using a nested viral primer and an adaptor primer 1 (AP1), which is complementary to the missing strand of the single-stranded part of the adaptor, was followed.
